Ferozsons Laboratories Limited (PSX: FEROZ) reported a 33% increase in its consolidated net profit for the fiscal year ended June 30, 2026, with profit after taxation climbing to Rs1.23bn compared to Rs921.71m in the previous year.
Reflecting this strong financial performance, the company's basic and diluted earnings per share (EPS) expanded to Rs22.51 from Rs17.86 in FY25. The Board of Directors has declared a final cash dividend of Rs5.50 per share (55%) for FY26.
| Financial Metric | FY26 | FY25 | YoY Change |
|---|---|---|---|
| Net Revenue | Rs23.96bn | Rs18.86bn | +27.05% |
| Gross Profit | Rs10.70bn | Rs7.99bn | +33.86% |
| Profit After Taxation | Rs1.23bn | Rs921.71m | +33.20% |
| Earnings Per Share (EPS) | Rs22.51 | Rs17.86 | +26.04% |
Net revenue grew 27% year-on-year to Rs23.96bn, supported by pricing strategies and product mix efficiencies, while gross profit advanced 34% to Rs10.70bn. Additionally, a 27% reduction in finance costs acted as a major tailwind supporting the bottom-line growth.
Read the full story on the original publisher’s website.
Open original article